Mode
Text Size
Log in / Sign up
N/A N=143 Health Services Research

HSS Covid-19 Antibody Serology Among Surgeons & Anesthesiologists

COVID

Enrolled (actual)
143
Serious AEs
Results posted
Jan 2024
Primary outcome: Primary: Number of Participants With SARS-CoV-2 IgG Antibodies — 14 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
SARS-CoV2 serum antibody testing (Diagnostic_test)
Age
Adult, Older Adult · 21+ yrs
Sex
All
Sponsor
Hospital for Special Surgery, New York
Primary completion
Jun 2020

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants With SARS-CoV-2 IgG Antibodies
14
SECONDARY
Differences in Sex Between IgG Antibody-positive vs. Negative Participants
2; 24; 12; 105
SECONDARY
Number of Asymptomatic Participants With Positive Antibody Serology
2
SECONDARY
Percentage of Antibody-positive Participants Who Subsequently Develop COVID-19
12
SECONDARY
Differences in Race Between IgG Antibody-positive vs. Negative Participants
10; 99; 2; 6; 2; 18
SECONDARY
Differences in Average Number of Adults in Household Between IgG Antibody-positive vs. Negative Participants
14; 129
SECONDARY
Differences in Comorbidities Between IgG Antibody-positive vs. Negative Participants
0; 13; 0; 1; 1; 9

Summary

The goal of this study is to understand the infectious exposure of SARS-coronavirus 2 (SARS-CoV2) among surgeons and anesthesiologists and to correlate this status with self-reported indices of COVID-19 illness.

Eligibility Criteria

Inclusion Criteria

  • Accredited to practice at HSS
  • All anesthesiology and surgery faculty
  • All anesthesia and orthopedic surgery fellows
  • All orthopedic surgery residents

Exclusion Criteria

  • Refusal to participate in either of the interventions at either of the timepoints of interest
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04389294). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search